Correlation Between Icosavax and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Icosavax and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Viridian Therapeutics, you can compare the effects of market volatilities on Icosavax and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Viridian Therapeutics.
Diversification Opportunities for Icosavax and Viridian Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Icosavax and Viridian is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Icosavax and Viridian Therapeutics
If you would invest 902.00 in Icosavax on September 27, 2024 and sell it today you would earn a total of 0.00 from holding Icosavax or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.55% |
Values | Daily Returns |
Icosavax vs. Viridian Therapeutics
Performance |
Timeline |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Viridian Therapeutics |
Icosavax and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Icosavax and Viridian Therapeutics
The main advantage of trading using opposite Icosavax and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Viridian Therapeutics vs. Fate Therapeutics | Viridian Therapeutics vs. Caribou Biosciences | Viridian Therapeutics vs. Karyopharm Therapeutics | Viridian Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |